Oncostatin M is a growth factor for Ewing sarcoma

American Journal of Pathology

Volumn 181, Issue 5, 2012, Pages 1782-1795

  David, Emmanuelle ^a,b   Tirode, Franck ^c,d   Baud'Huin, Marc ^a,b,e   Guihard, Pierre ^a,b   Laud, Karine ^c,d   Delattre, Olivier ^c,d   Heymann, Marie F ^a,e   Heymann, Dominique ^a,b,e   Redini, Françoise ^a,b,e   Blanchard, Frédéric ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c INSTITUT CURIE   (France)

^d INSTITUT CURIE   (France)

^e NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKEMIA INHIBITORY FACTOR RECEPTOR; ONCOSTATIN M; STAT3 PROTEIN;

ARTICLE; CELL PROLIFERATION; CHONDROSARCOMA; CLINICAL ARTICLE; CYTOKINE PRODUCTION; EWING SARCOMA; GLIOMA; HUMAN; HUMAN CELL; LYSOSOME; MEDULLOBLASTOMA; NEUROBLASTOMA; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; XENOGRAFT;

ANIMALS; BONE NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CHONDROSARCOMA; CYTOKINE RECEPTOR GP130; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA INHIBITORY FACTOR; MESODERM; MICE; MODELS, BIOLOGICAL; ONCOGENE PROTEINS, FUSION; ONCOSTATIN M; OSTEOSARCOMA; PROTEIN SUBUNITS; PROTO-ONCOGENE PROTEIN C-FLI-1; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, ONCOSTATIN M; RECEPTORS, OSM-LIF; RNA-BINDING PROTEIN EWS; SARCOMA, EWING; STAT3 TRANSCRIPTION FACTOR;

EID: 84868091639     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.07.023     Document Type: Article

References (57)

1. P. Picci Osteosarcoma (osteogenic sarcoma) Orphanet J Rare Dis 2 2007 6
2. M. Bernstein, H. Kovar, M. Paulussen, R.L. Randall, A. Schuck, L.A. Teot, H. Juergens Ewing's sarcoma family of tumors: current management Oncologist 11 2006 503 519 (Pubitemid 43788277)
3. A.B. Mohseny, K. Szuhai, S. Romeo, E.P. Buddingh, I. Briaire-de Bruijn, D. de Jong, M. van Pel, A.M. Cleton-Jansen, P.C. Hogendoorn Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2 J Pathol 219 2009 294 305
4. S. Boeuf, P. Kunz, T. Hennig, B. Lehner, P. Hogendoorn, J. Bovee, W. Richter A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma J Pathol 216 2008 158 166
5. B. Wadayama, J. Toguchida, T. Yamaguchi, M.S. Sasaki, T. Yamamuro p53 Expression and its relationship to DNA alterations in bone and soft tissue sarcomas Br J Cancer 68 1993 1134 1139 (Pubitemid 23356665)
6. O. Delattre, J. Zucman, B. Plougastel, C. Desmaze, T. Melot, M. Peter, H. Kovar, I. Joubert, P. de Jong, G. Rouleau, A. Aurias, G. Thomas Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours Nature 359 1992 162 165
7. W.A. May, M.L. Gishizky, S.L. Lessnick, L.B. Lunsford, B.C. Lewis, O. Delattre, J. Zucman, G. Thomas, C.T. Denny Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation Proc Natl Acad Sci U S A 90 1993 5752 5756 (Pubitemid 23176240)
8. F. Tirode, K. Laud-Duval, A. Prieur, B. Delorme, P. Charbord, O. Delattre Mesenchymal stem cell features of Ewing tumors Cancer Cell 11 2007 421 429 (Pubitemid 46680428)
9. N. Riggi, M.L. Suva, C. De Vito, P. Provero, J.C. Stehle, K. Baumer, L. Cironi, M. Janiszewska, T. Petricevic, D. Suva, S. Tercier, J.M. Joseph, L. Guillou, I. Stamenkovic EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells Genes Dev 24 2010 916 932
10. A. Rocchi, M.C. Manara, M. Sciandra, D. Zambelli, F. Nardi, G. Nicoletti, C. Garofalo, S. Meschini, A. Astolfi, M.P. Colombo, S.L. Lessnick, P. Picci, K. Scotlandi CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis J Clin Invest 120 2010 668 680
11. F.Y. Lee, H.J. Mankin, G. Fondren, M.C. Gebhardt, D.S. Springfield, A.E. Rosenberg, L.C. Jennings Chondrosarcoma of bone: an assessment of outcome J Bone Joint Surg Am 81 1999 326 338 (Pubitemid 29153210)
12. S.J. Cotterill, S. Ahrens, M. Paulussen, H.F. Jurgens, P.A. Voute, H. Gadner, A.W. Craft Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group J Clin Oncol 18 2000 3108 3114
13. K. Mori, F. Rédini, F. Gouin, B. Cherrier, D. Heymann Osteosarcoma: current status of immunotherapy and future trends (review) Oncol Rep 15 2006 693 700
14. P.C. Heinrich, I. Behrmann, S. Haan, H.M. Hermanns, G. Muller-Newen, F. Schaper Principles of interleukin (IL)-6-type cytokine signalling and its regulation Biochem J 374 2003 1 20 (Pubitemid 37046923)
15. S.H. Chen, E.N. Benveniste Oncostatin M: a pleiotropic cytokine in the central nervous system Cytokine Growth Factor Rev 15 2004 379 391 (Pubitemid 39144383)
16. F. Blanchard, L. Duplomb, M. Baud'huin, B. Brounais The dual role of IL-6-type cytokines on bone remodeling and bone tumors Cytokine Growth Factor Rev 20 2009 19 28
17. A. Grenier, M. Dehoux, A. Boutten, M. Arce-Vicioso, G. Durand, M.A. Gougerot-Pocidalo, S. Chollet-Martin Oncostatin M production and regulation by human polymorphonuclear neutrophils Blood 93 1999 1413 1421 (Pubitemid 29076158)
18. J.M. Zarling, M. Shoyab, H. Marquardt, M.B. Hanson, M.N. Lioubin, G.J. Todaro Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells Proc Natl Acad Sci U S A 83 1986 9739 9743 (Pubitemid 17223432)
19. D. Arthan, S.K. Hong, J.I. Park Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells Cancer Lett 297 2010 31 41
20. B. Brounais, C. Chipoy, K. Mori, C. Charrier, S. Battaglia, P. Pilet, C.D. Richards, D. Heymann, F. Redini, F. Blanchard Oncostatin M induces bone loss and sensitizes rat osteosarcoma to the antitumor effect of Midostaurin in vivo Clin Cancer Res 14 2008 5400 5409
21. C. Chipoy, B. Brounais, V. Trichet, S. Battaglia, M. Berreur, L. Oliver, P. Juin, F. Redini, D. Heymann, F. Blanchard Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53 Oncogene 26 2007 6653 6664 (Pubitemid 47573687)
22. B. Brounais, E. David, C. Chipoy, V. Trichet, V. Ferre, C. Charrier, L. Duplomb, M. Berreur, F. Redini, D. Heymann, F. Blanchard Long term oncostatin M treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cells Bone 44 2009 830 839
23. E. David, P. Guihard, B. Brounais, A. Riet, C. Charrier, S. Battaglia, F. Gouin, S. Ponsolle, R.L. Bot, C.D. Richards, D. Heymann, F. Redini, F. Blanchard Direct anti-cancer effect of oncostatin M on chondrosarcoma Int J Cancer 128 2011 1822 1835
24. C. Langdon, C. Kerr, M. Hassen, T. Hara, A.L. Arsenault, C.D. Richards Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo Am J Pathol 157 2000 1187 1196
25. A. Lundquist, B. Barre, F. Bienvenu, J. Hermann, S. Avril, O. Coqueret Kaposi sarcoma-associated viral cyclin K overrides cell growth inhibition mediated by oncostatin M through STAT3 inhibition Blood 101 2003 4070 4077 (Pubitemid 36857888)
26. A. Lacreusette, A. Lartigue, J.M. Nguyen, I. Barbieux, M.C. Pandolfino, F. Paris, A. Khammari, B. Dréno, Y. Jacques, F. Blanchard, A. Godard Relationship between responsiveness of cancer cells to Oncostatin M and/or IL-6 and survival of stage III melanoma patients treated with tumour-infiltrating lymphocytes J Pathol 216 2008 451 459
27. A. Lacreusette, J.M. Nguyen, M.C. Pandolfino, A. Khammari, B. Dreno, Y. Jacques, A. Godard, F. Blanchard Loss of oncostatin M receptor beta in metastatic melanoma cells Oncogene 26 2007 881 892
28. H. Hirai, P. Karian, N. Kikyo Regulation of embryonic stem cell self-renewal and pluripotency by leukaemia inhibitory factor Biochem J 438 2011 11 23
29. J.E. Shin, S.H. Park, Y.K. Jang Epigenetic up-regulation of leukemia inhibitory factor (LIF) gene during the progression to breast cancer Mol Cells 31 2011 181 189
30. S. Maruta, S. Takiguchi, M. Ueyama, Y. Kataoka, Y. Oda, M. Tsuneyoshi, H. Iguchi A role for leukemia inhibitory factor in melanoma-induced bone metastasis Clin Exp Metastasis 26 2009 133 141
31. M. Kortylewski, P.C. Heinrich, A. Mackiewicz, U. Schniertshauer, U. Klingmuller, K. Nakajima, T. Hirano, F. Horn, I. Behrmann Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1 Oncogene 18 1999 3742 3753 (Pubitemid 29338507)
32. T. Bellido, C.A. O'Brien, P.K. Roberson, S.C. Manolagas Transcriptional activation of the p21(WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines: a prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells J Biol Chem 273 1998 21137 21144 (Pubitemid 28385402)
33. J.A. Hutt, J.W. DeWille Oncostatin M induces growth arrest of mammary epithelium via a CCAAT/enhancer-binding protein δ-dependent pathway Mol Cancer Ther 1 2002 601 610
34. N. Guillon, F. Tirode, V. Boeva, A. Zynovyev, E. Barillot, O. Delattre The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function PLoS One 4 2009 e4932
35. F. Blanchard, Y. Wang, E. Kinzie, L. Duplomb, A. Godard, H. Baumann Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor α, and oncostatin M receptor β by distinct mechanisms J Biol Chem 276 2001 47038 47045
36. P. Guihard, Y. Danger, B. Brounais, E. David, R. Brion, J. Delecrin, C.D. Richards, S. Chevalier, F. Redini, D. Heymann, H. Gascan, F. Blanchard Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling Stem Cells 30 2012 762 772
37. D. Williamson, E. Missiaglia, A. de Reynies, G. Pierron, B. Thuille, G. Palenzuela, K. Thway, D. Orbach, M. Lae, P. Freneaux, K. Pritchard-Jones, O. Oberlin, J. Shipley, O. Delattre Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma J Clin Oncol 28 2010 2151 2158
38. M. Dai, P. Wang, A.D. Boyd, G. Kostov, B. Athey, E.G. Jones, W.E. Bunney, R.M. Myers, T.P. Speed, H. Akil, S.J. Watson, F. Meng Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data Nucleic Acids Res 33 2005 e175
39. F. Blanchard, L. Duplomb, Y. Wang, O. Robledo, E. Kinzie, V. Pitard, A. Godard, Y. Jacques, H. Baumann Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinase J Biol Chem 275 2000 28793 28801
40. E.A. Kritikou, A. Sharkey, K. Abell, P.J. Came, E. Anderson, R.W. Clarkson, C.J. Watson A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland Development 130 2003 3459 3468 (Pubitemid 37010009)
41. T. Matsui, T. Kinoshita, T. Hirano, T. Yokota, A. Miyajima STAT3 down-regulates the expression of cyclin D during liver development J Biol Chem 277 2002 36167 36173
42. Q. Li, J. Zhu, F. Sun, L. Liu, X. Liu, Y. Yue Oncostatin M promotes proliferation of ovarian cancer cells through signal transducer and activator of transcription 3 Int J Mol Med 28 2011 101 108
43. L. Daheron, S.L. Opitz, H. Zaehres, M.W. Lensch, P.W. Andrews, J. Itskovitz-Eldor, G.Q. Daley LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells Stem Cells 22 2004 770 778 (Pubitemid 39166934)
44. Y. Lu, S. Fukuyama, R. Yoshida, T. Kobayashi, K. Saeki, H. Shiraishi, A. Yoshimura, G. Takaesu Loss of SOCS3 gene expression converts STAT3 function from anti-apoptotic to pro-apoptotic J Biol Chem 281 2006 36683 36690 (Pubitemid 46042135)
45. P.G. Ziros, T. Georgakopoulos, I. Habeos, E.K. Basdra, A.G. Papavassiliou Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3β J Bone Miner Res 19 2004 1892 1904 (Pubitemid 41103441)
46. K.M. Foshay, G.I. Gallicano Regulation of Sox2 by STAT3 initiates commitment to the neural precursor cell fate Stem Cells Dev 17 2008 269 278 (Pubitemid 351630169)
47. B.L. Kidder, J. Yang, S. Palmer Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells PLoS One 3 2008 e3932
48. X. Chen, H. Xu, P. Yuan, F. Fang, M. Huss, V.B. Vega, E. Wong, Y.L. Orlov, W. Zhang, J. Jiang, Y.H. Loh, H.C. Yeo, Z.X. Yeo, V. Narang, K.R. Govindarajan, B. Leong, A. Shahab, Y. Ruan, G. Bourque, W.K. Sung, N.D. Clarke, C.L. Wei, H.H. Ng Integration of external signaling pathways with the core transcriptional network in embryonic stem cells Cell 133 2008 1106 1117 (Pubitemid 351787745)
49. C.E. Kan, R. Cipriano, M.W. Jackson c-MYC functions as a molecular switch to alter the response of human mammary epithelial cells to oncostatin M Cancer Res 71 2011 6930 6939
50. L. Dauphinot, C. De Oliveira, T. Melot, N. Sevenet, V. Thomas, B.E. Weissman, O. Delattre Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2 and c-Myc expression Oncogene 20 2001 3258 3265 (Pubitemid 32553678)
51. M. Fukuma, H. Okita, J. Hata, A. Umezawa Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma Oncogene 22 2003 1 9 (Pubitemid 36152878)
52. S.L. Fossey, M.D. Bear, W.C. Kisseberth, M. Pennell, C.A. London Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines BMC Cancer 11 2011 125
53. W.M. Elbjeirami, E.M. Donnachie, A.R. Burns, C.W. Smith Endothelium-derived GM-CSF influences expression of oncostatin M Am J Physiol Cell Physiol 301 2011 C947 C953
54. A. Pession, R. Tonelli The MYCN oncogene as a specific and selective drug target for peripheral and central nervous system tumors Curr Cancer Drug Targets 5 2005 273 283 (Pubitemid 40910560)
55. S. Ball, C. Li, P.K. Li, J. Lin The small molecule, LLL12, inhibits STAT3 phosphorylation and induces apoptosis in medulloblastoma and glioblastoma cells PLoS One 6 2011 e18820
56. J. Liu, J.W. Li, Y. Gang, L. Guo, H. Li Expression of leukemia-inhibitory factor as an autocrinal growth factor in human medulloblastomas J Cancer Res Clin Oncol 125 1999 475 480 (Pubitemid 29410411)
57. H. Wang, J.D. Lathia, Q. Wu, J. Wang, Z. Li, J.M. Heddleston, C.E. Eyler, J. Elderbroom, J. Gallagher, J. Schuschu, J. MacSwords, Y. Cao, R.E. McLendon, X.F. Wang, A.B. Hjelmeland, J.N. Rich Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth Stem Cells 27 2009 2393 2404